Articles from Adverse Event Reporting News (May 21, 2007)

Title	Author	Type	Words
American University to hold discussions on pending FDA reform law.			475
Anemia drugs face increasing questions at FDA.	Mashaw, Rebecca		601
Astellas Pharma says patient died in anemia drug trial.		Brief article	131
Biotech firms fear FDA reform, PDUFA will crimp drug development.	Cezanne, Jeannette		634
Compliance committee recommended to deal with FDA, pharmacy requirements.	Cezanne, Jeannette		379
Electric pulses, instead of shocks, can help heart patients.			357
FDA continuing meta-analysis of studies on Avandia, but isn't ready to take regulatory action, CDER officials say.			748
FDA issues new guidance on labeling for pharmacologic class.			426
Health Canada warns patients taking anti-epilepsy medications.		Brief article	198
Ireland orders withdrawal of nimesulide anti-arthritis drug.			370
Iressa does not prolong life, may cause bleeding in head and neck cancer patients.			216
Lilly's Actos trial shows increased fracture risk in women.			468
MedDRA board commits to providing free access for AE reports.		Brief article	256
Medicare may limit coverage of anemia drugs.			483
Migraine patients taking unapproved drugs at risk for side effects.		Survey	703
Mixed verdict HRT trial yields win for Wyeth, loss for Pfizer.			464
Senate passes drug safety/PDUFA bill; House could act by May 28.			905
Soldier's smallpox inoculation sickens son.			584